Noopept / Omberacetam

9 indexed publications · 2 human studies · research from 2002 to 2019

Research goals studied

Noopept Does Not Stimulate Cell Proliferation in Tested Models
2019 · Preclinical
Assessed whether Noopept promotes proliferation in tested cell models.
Neuroprotective Effects of Noopept Under Oxidative Stress
2014 · Preclinical
Examined cellular neuroprotection by Noopept under oxidative stress.
Noopept in Mild Cognitive Impairment After Ischemic Stroke
2011 · Human evidence
Clinical report evaluating Noopept in patients with post-stroke mild cognitive impairment.
Strategy for Development of Dipeptide Neuropsychotropic Drugs
2011 · Preclinical
Reviews development strategy for Russian dipeptide-derived neuropsychotropic agents.
Comparative Effects of Noopept and Piracetam
2009 · Preclinical
Compared behavioral and molecular effects of Noopept and piracetam.
Noopept Stimulates NGF and BDNF Expression in Rat Brain
2008 · Preclinical
Assessed NGF and BDNF expression after Noopept administration.
Clinical and EEG Characteristics of Noopept Therapy
2008 · Human evidence
Clinical and electroencephalographic evaluation during Noopept treatment.
Noopept in an Experimental Model of Alzheimer Disease
2007 · Preclinical
Evaluated Noopept in an experimental Alzheimer-type model.
Noopept and Cyclo-L-Prolylglycine: Comparative Nootropic Activity
2002 · Preclinical
Compared Noopept with cyclo-L-prolylglycine in behavioral models.

Convert a vial to draw volume on the peptide calculator, or track protocols and vials in the free app.